In the U.K., two instances of evidently inept work by radiologists are inadvertently spotlighting the value of subspecialized image interpretation in socially sensitive patient cases.

A global tech and pharma supplier that introduced a generic equivalent to GE Healthcare’s Visipaque during the height of the 2022 contrast shortage has begun offering a substitute for Guerbet’s Dotarem.

Why are patients paying far less out of their pockets for mammography now than two decades ago—while shelling out a lot more for other common imaging exams?

Use of the barrier reduced associated insertion costs at one institution by 73% and insertion time by 50%. 

Diabetes and atrial fibrillation are just some of the factors that can increase a patient's risk of being hospitalized for heart failure within one year of undergoing a successful TAVR procedure.

An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.

If generalizable AI models are to meaningfully contribute to precision cancer care, they’ll need to incorporate not only imaging data but also digitalized clinical notes, biomarker assays and monitor readouts.

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out.